Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 319,661 | 256,280 | 341,476 | 270,668 | 805,113 |
| Gross Profit | 319,661 | 256,280 | 341,476 | 270,668 | 805,113 |
| Operating Expenses | 192,089 | 170,043 | 183,724 | 135,962 | 140,906 |
| Operating Income | 127,573 | 86,237 | 157,752 | 134,706 | 664,207 |
| Interest Expense | 69,703 | 12,320 | 94,186 | 113,040 | 31,165 |
| Other Income | 10,537 | 156,913 | 44,048 | 83,681 | 6,203 |
| Pre-tax Income | 68,406 | 230,830 | 107,614 | 105,347 | 639,246 |
| Income Tax | 18,804 | 53,169 | 561 | 22,137 | 140,315 |
| Net Income Continuous | 49,603 | 177,662 | 107,054 | 83,210 | 498,931 |
| Net Income | $49,603 | $177,662 | $107,054 | $83,210 | $498,931 |
| EPS Basic Total Ops | 0.76 | 2.72 | 1.63 | 1.28 | 7.66 |
| EPS Basic Continuous Ops | 0.76 | 2.72 | 1.63 | 1.28 | 7.66 |
| EPS Diluted Total Ops | 0.75 | 2.69 | 1.61 | 1.26 | 7.58 |
| EPS Diluted Continuous Ops | 0.75 | 2.69 | 1.61 | 1.26 | 7.58 |
| EBITDA(a) | $127,573 | $86,237 | $157,752 | $134,706 | $664,207 |